Effect of Insulin Therapy using Hyper-insulinemic Normoglycemic Clamp on Inflammatory Response in Brain Dead Organ Donors.

BACKGROUND Brain death is a major stress that is associated with a massive inflammatory response and systemic hyperglycemia. Severe inflammation leads to increased graft immunogenicity and risk of graft dysfunction; while acute hyperglycemia aggravates the inflammatory response and increases the risk of morbidity and mortality. Insulin therapy not only controls hyperglycemia but also suppresses inflammation. The present study is to investigate the anti-inflammatory properties and the normoglycemia maintenance of high dose insulin on brain dead organ donors. DESIGN 15 brain dead organ donors were divided into 2 groups, insulin treated (n=6) and controls (n=9). Insulin was provided for a minimum of 6 h using the hyperinsulinemic normoglycemic clamp technique. The changes of serum cytokines, including IL-6, IL-10, IL-1β, IL-8, TNFα, TGFα and MCP-1, were measured by suspension bead array immunoassay and glucose by a glucose monitor. RESULTS Compared to controls, insulin treated donors had a significant lower blood glucose 4.8 (4-6.9) vs. 9 (5.6-11.7) mmol/L, p<0.01); the net decreases of pro-inflammatory cytokines, such as IL-6 and MCP-1, and the net increase of anti-inflammatory cytokine, such as IL-10, reached significant level in insulin treated donors compared with those in controls. CONCLUSION High dose insulin therapy decreases the concentrations of inflammatory cytokines in brain dead donors and preserves normoglycemia. High dose of insulin may have anti-inflammatory effects in brain dead organ donors and therefore, improve the quality of donor organs and potentially improve outcomes.

[1]  A. Hartmann,et al.  Early Posttransplantation Hyperglycemia in Kidney Transplant Recipients Is Associated With Overall Long-term Graft Losses , 2012, Transplantation.

[2]  J. Bugge Brain death and its implications for management of the potential organ donor , 2009, Acta anaesthesiologica Scandinavica.

[3]  G. Paolisso,et al.  Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients. , 2009, Journal of the American College of Cardiology.

[4]  A. Barklin,et al.  Systemic inflammation in the brain‐dead organ donor , 2009, Acta anaesthesiologica Scandinavica.

[5]  P. Neuhaus,et al.  Methylprednisolone Therapy in Deceased Donors Reduces Inflammation in the Donor Liver and Improves Outcome After Liver Transplantation: A Prospective Randomized Controlled Trial , 2008, Annals of surgery.

[6]  P. Metrakos,et al.  Hepatic protection by perioperative metabolic support? , 2008, Nutrition.

[7]  K. Lachapelle,et al.  High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients. , 2008, The Annals of thoracic surgery.

[8]  J. Kellum,et al.  Increased plasma interleukin-6 in donors is associated with lower recipient hospital-free survival after cadaveric organ transplantation* , 2008, Critical care medicine.

[9]  O. Schmitz,et al.  Insulin alters cytokine content in two pivotal organs after brain death: a porcine model , 2008, Acta anaesthesiologica Scandinavica.

[10]  M. Miyazaki,et al.  Poor postoperative blood glucose control increases surgical site infections after surgery for hepato-biliary-pancreatic cancer: a prospective study in a high-volume institute in Japan. , 2008, The Journal of hospital infection.

[11]  G. Choukroun,et al.  Insulin maintains plasma antioxidant capacity at an early phase of kidney transplantation. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  G. Hotamisligil,et al.  Inflammation and metabolic disorders , 2006, Nature.

[13]  D. Fry,et al.  Acute hyperglycemia and the innate immune system: Clinical, cellular, and molecular aspects , 2005, Critical care medicine.

[14]  P. Neuhaus,et al.  What can be learned from brain‐death models? , 2005, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  F. Delmonico,et al.  Aggressive pharmacologic donor management results in more transplanted organs1 , 2003, Transplantation.

[16]  Y. Hwang,et al.  Hepatocyte protection by a protease inhibitor against ischemia/reperfusion injury of human liver. , 2002, Journal of the American College of Surgeons.

[17]  K. Hoya,et al.  Acute Systemic Inflammatory Response Syndrome in Subarachnoid Hemorrhage , 2001, Stroke.

[18]  T. Billiar,et al.  Molecular mechanisms in the early phase of hemorrhagic shock , 2001, Langenbeck’s Archives of Surgery.

[19]  M. Wilhelm,et al.  Early and late inflammatory changes occurring in rat renal isografts from brain dead donors. , 2001, Transplantation proceedings.

[20]  D. Pinsky,et al.  The endothelial response to oxygen deprivation: biology and clinical implications , 2001, Intensive Care Medicine.

[21]  M. Yacoub,et al.  Elevated Tumor Necrosis Factor-&agr; and Interleukin-6 in Myocardium and Serum of Malfunctioning Donor Hearts , 2000, Circulation.

[22]  A. Khaghani,et al.  Tumor necrosis factor-alpha is expressed in donor heart and predicts right ventricular failure after human heart transplantation. , 2000, Circulation.

[23]  S. Fuggle,et al.  Cadaver versus living donor kidneys: impact of donor factors on antigen induction before transplantation. , 1999, Kidney international.

[24]  P. Corris,et al.  Enhanced pulmonary inflammation in organ donors following fatal non-traumatic brain injury , 1999, The Lancet.

[25]  D. V. van Thiel,et al.  Ischemia‐reperfusion injury in rat fatty liver: Role of nutritional status , 1999, Hepatology.

[26]  D. Salant,et al.  RANTES and Monocyte Chemoattractant Protein–1 (MCP-1) Play an Important Role in the Inflammatory Phase of Crescentic Nephritis, but Only MCP-1 Is Involved in Crescent Formation and Interstitial Fibrosis , 1997, The Journal of experimental medicine.

[27]  O. Ljungqvist,et al.  Pre-stress carbohydrate solution prevents fatal outcome after hemorrhage in 24-hour food-deprived rats. , 1996, Nutrition.

[28]  G. Breithardt,et al.  The relation of interleukin-6, tumor necrosis factor-alpha, IL-2, and IL-2 receptor levels to cellular rejection, allograft dysfunction, and clinical events early after cardiac transplantation. , 1995, Transplantation.

[29]  C. McClain,et al.  Cytokines and metabolic dysfunction after severe head injury. , 1994, Journal of neurotrauma.

[30]  D. L. Le Couteur,et al.  The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver. , 1994, Transplantation.

[31]  M. Lindholm Critically ill patients and fat emulsions. , 1992, Minerva anestesiologica.

[32]  H. Bismuth,et al.  High levels of glycogen in the donor liver improve survival after liver transplantation in rats. , 1991, Transplantation proceedings.

[33]  K. Cianflone,et al.  High-dose insulin therapy reduces postoperative liver dysfunction and complications in liver resection patients through reduced apoptosis and altered inflammation. , 2012, The Journal of clinical endocrinology and metabolism.

[34]  G. V. Berghe,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[35]  T. Stanford The potential organ donor. , 1986, Emergency.